Strong operations, real RCD risk
- EHC is the largest U.S. owner and operator of inpatient rehabilitation hospitals, known as IRFs.
- Q1 2026 net operating revenue rose 9.0%, helped by volume growth and better pricing.
- Labor is moving the right way, with premium labor spend down 9.4% and RN turnover at 17.8%.
- Medicare is the biggest payer, so government rules can quickly affect cash collection.
- The main bear case is the Review Choice Demonstration program in Alabama, Texas, and California.
Execution is winning, for now
Encompass Health is showing clear operating momentum. In Q1 2026, net operating revenue increased 9.0% from the prior year, and adjusted EPS rose 16.8%. Management also raised full-year 2026 revenue guidance to $6.375 billion to $6.470 billion, a small but useful sign that demand and pricing are holding up.
The strongest part of the story is labor. Premium labor spend fell 9.4% year over year, contract labor stayed very low, and RN turnover dropped to 17.8%, the lowest level since 2012. For a hospital operator, that matters because nurses and therapists are both the product and one of the largest costs.
The risk is not hidden. The Review Choice Demonstration, or RCD, is a Medicare review program that checks claims before or after payment. Encompass says reviews in Alabama have been inconsistent and improper, and the program has expanded to Texas and California. That makes collections and administrative costs harder to forecast.
Finn’s view is balanced. EHC is executing well, but the stock is not a simple cheap-growth story. The next big proof points are RCD affirmation rates in Texas and California, continued labor gains, and whether management turns talk of a future buyback into a real capital return plan.
Paid when patients leave rehab
Encompass Health makes money by treating patients in inpatient rehabilitation hospitals. These patients usually come from acute-care hospitals after events such as strokes, neurological problems, brain or spinal cord injuries, complex orthopedic conditions, cardiac and pulmonary issues, or amputations.
Revenue is mostly earned per discharge. In Q1 2026, Medicare paid $1.0385 billion of the company’s $1.5866 billion in net operating revenue. Medicare Advantage, managed care, Medicaid, and other payers made up the rest. That payer mix gives EHC steady demand, but it also ties the business to government payment rules.
Growth comes from adding capacity. EHC builds new hospitals, called de novos, and adds beds to existing hospitals. Management also says prefabricated construction can improve speed-to-market for new hospitals by about 25%, which can help new capacity start earning sooner.
The model breaks if claims are denied, nurses get scarce, or hospitals cannot fill new beds. So the key question is simple: can EHC keep growing discharges while collecting cleanly from Medicare and keeping labor costs under control?
Rehab care, not broad hospitals
Stroke rehabilitation
Stroke is one of EHC’s most common patient types. These patients often need intensive therapy before they can safely go home.
Neurological rehabilitation
This includes complex neurological conditions that require coordinated care from nurses, therapists, and doctors. It supports the company’s core value of getting patients home and reducing readmissions.
Orthopedic and amputation rehabilitation
Patients recovering from complex orthopedic events or amputations may need inpatient rehab before daily life is possible again. This is a steady part of the IRF service mix.
Cardiac and pulmonary rehabilitation
Some patients recovering from heart or lung conditions need higher-intensity rehab than a nursing facility can provide. EHC serves them in dedicated hospital settings.
Brain and spinal cord injury rehabilitation
These cases can be complex and resource-heavy. They fit EHC’s focus on serious injuries that require coordinated inpatient care.
New hospitals and bed additions
Capacity expansion is the main growth engine. EHC builds de novo hospitals and adds beds where demand supports more inpatient rehab capacity.
One segment, mostly inpatient
EHC reports one operating and reportable segment: inpatient rehabilitation. The mix below uses Q1 2026 service-line revenue detail from the 10-Q, where inpatient revenue was $1.5337 billion and other revenue was $52.9 million.
What could break the case
RCD claim reviews spread badly
High impact · Medium oddsThe Review Choice Demonstration program is the main risk. EHC says Alabama reviews have varied by cycle and that many non-affirmations were based on inconsistent and improper standards. The program now applies to Texas and California too, which makes the issue much larger than Alabama.
Labor savings reverse
Medium impact · Medium oddsEHC’s Q1 2026 labor results were strong, with premium labor spend down 9.4% and RN turnover at 17.8%. That lowers near-term risk. But hospitals still compete hard for nurses and therapists, so wage pressure can return.
Medicare Advantage pressure rises
Medium impact · Medium oddsMedicare Advantage and managed care are important payers after Medicare. If plans deny more referrals, lower conversion rates, or push patients to cheaper settings, discharge growth and pricing can weaken. Management already called out challenges with one national Medicare Advantage payer in Q4 2025.
New capacity opens too slowly
Medium impact · Low oddsThe growth plan depends on opening new hospitals and adding beds. Prefabricated construction may help speed openings, but projects can still face delays, staffing limits, or weak local demand. If new beds do not fill, returns on capital fall.
Storms disrupt core markets
Medium impact · Medium oddsEHC has hospital concentration in the Southeast and Texas. Hurricanes and severe weather can disrupt staffing, patient admissions, utilities, and local hospital referrals. This is a structural risk, not a one-quarter issue.